| Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 01/08/2023| bse |
| Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| 31/07/2023| bse |
| Statement Of Deviation And Variation Under Regulation 32 |
| 31/07/2023| bse |
| Appointment Of Independent Directors |
| 31/07/2023| bse |
| Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s |
| 31/07/2023| bse |
| Results- Financial Results For Quarter Ended June 30 2023 |
| 31/07/2023| bse |
| Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| 13/07/2023| bse |
| Intimation About Receipt Of FDA License |
| 12/07/2023| bse |
| Closure of Trading Window |
| 29/06/2023| bse |
| Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| 20/06/2023| bse |
| Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A |
| 29/04/2023| bse |
| Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 |
| 26/04/2023| bse |
| Certificate Under Regulation 40 (9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations 2015 For Year Ended On March 31 2023. |
| 13/04/2023| bse |
| Compliance Certificate Pursuant To Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Year Ended On March 31 2023. |
| 11/04/2023| bse |
| Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 |
| 06/04/2023| bse |
| Closure of Trading Window |
| 27/03/2023| bse |
| Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 10/03/2023| bse |
